| Dr Patricia Boehle, DPM | |
|
608 Nw 9th St Ste 3110, Oklahoma City, OK 73102-1049 | |
| (405) 272-7055 | |
| (405) 272-7059 |
| Full Name | Dr Patricia Boehle |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 6 Years |
| Location | 608 Nw 9th St Ste 3110, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326544578 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 375 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Anthony Hospital - Oklahoma City | Oklahoma city, OK | Hospital |
| Ssm Health St Anthony Hospital - Shawnee | Shawnee, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Medical Group, Llc | 7012914898 | 298 |
News Archive
Drugs like crizotinib are used to treat patients with ROS1-positive lung cancer. But which patients are ROS1-positive? A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology shows that common laboratory tests used to determine ROS1 status all have inherent limitations that can lead to false-negative results.
A experimental trial has shown successful by inducing serum in mice and has been highly neutralizing towards those ailments.
We stumbled upon this news a couple weeks back regarding Cannabis Science, Inc. reported the continuing successful progress by two patients who have been topically self-administering Cannabis Science extracts for Squamous Cell Carcinoma Cancer and Skin Cancer.
Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient's breathing and activity levels every day.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
› Verified 2 days ago
| Provider Name | Saint Medical Group, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437195922 PECOS PAC ID: 7012914898 Enrollment ID: O20061109000189 |
News Archive
Drugs like crizotinib are used to treat patients with ROS1-positive lung cancer. But which patients are ROS1-positive? A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology shows that common laboratory tests used to determine ROS1 status all have inherent limitations that can lead to false-negative results.
A experimental trial has shown successful by inducing serum in mice and has been highly neutralizing towards those ailments.
We stumbled upon this news a couple weeks back regarding Cannabis Science, Inc. reported the continuing successful progress by two patients who have been topically self-administering Cannabis Science extracts for Squamous Cell Carcinoma Cancer and Skin Cancer.
Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient's breathing and activity levels every day.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia Boehle, DPM 608 Nw 9th St Ste 3110, Oklahoma City, OK 73102-1049 Ph: (405) 272-7055 | Dr Patricia Boehle, DPM 608 Nw 9th St Ste 3110, Oklahoma City, OK 73102-1049 Ph: (405) 272-7055 |
News Archive
Drugs like crizotinib are used to treat patients with ROS1-positive lung cancer. But which patients are ROS1-positive? A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology shows that common laboratory tests used to determine ROS1 status all have inherent limitations that can lead to false-negative results.
A experimental trial has shown successful by inducing serum in mice and has been highly neutralizing towards those ailments.
We stumbled upon this news a couple weeks back regarding Cannabis Science, Inc. reported the continuing successful progress by two patients who have been topically self-administering Cannabis Science extracts for Squamous Cell Carcinoma Cancer and Skin Cancer.
Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient's breathing and activity levels every day.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
› Verified 2 days ago
Dr. Terry M Nayfa, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3612 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-947-5492 Fax: 405-947-5532 | |
Timothy D Thomas, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. John Andrew Maupin Jr., DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 705 Nw 57th St, Oklahoma City, OK 73118 Phone: 405-550-0060 | |
David G. Wade Dpm Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3330 Nw 56th St, #600, Oklahoma City, OK 73112 Phone: 405-947-8041 | |
Alaina Janae Jones, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. Nicholas B Plants, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9315 S. Pennsylvania Ave, Suite A, Oklahoma City, OK 73159 Phone: 405-691-9004 Fax: 405-691-9003 | |
Peter Quoc Le Podiatrist Medicare: Medicare Enrolled Practice Location: 2201 N Meridian Ave, Oklahoma City, OK 73107 Phone: 405-943-9820 Fax: 405-947-6908 |